ELIA B2-GLYCOPROTEIN I IGA IMMUNOASSAY— 510(k) K112414

Substantially Equivalent

Phadia US, Inc.

FDA 510(k) clearance K112414 for ELIA B2-GLYCOPROTEIN I IGA IMMUNOASSAY, Substantially Equivalent on 2012-06-22. Applicant: Phadia US, Inc..

Clearance details

Applicant
Phadia US, Inc.
Product code
Code MSV
Advisory panel
Immunology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Portage, MI, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.